Tonix Pharmaceuticals stock halted ahead of FDA approval news
Investing.com - Affirm Holdings (NASDAQ: AFRM) reported second quarter EPS of $-0.14, $0.37 better than the analyst estimate of $-0.51. Revenue for the quarter came in at $659.19M versus the consensus estimate of $603.67M.
Guidance
Affirm Holdings sees Q1 2025 revenue of $640.00M-$670.00M versus the analyst consensus of $624.60M.
Affirm Holdings's stock price closed at $31.58. It is up 7.89% in the last 3 months and up 64.60% in the last 12 months.
Affirm Holdings saw 0 positive EPS revisions and 0 negative EPS revisions in the last 90 days. See Affirm Holdings's stock price’s past reactions to earnings here.
According to InvestingPro, Affirm Holdings's Financial Health score is "fair performance".
Check out Affirm Holdings's recent earnings performance, and Affirm Holdings's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar